SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Hester Biosciences - Quaterly Results

31 Jan 2026 Evaluate
The revenue zoomed 11.98% to Rs. 703.54 millions for the quarter ended December 2025 as compared to Rs. 628.26 millions during the corresponding quarter last year.The Total revenue for the quarter ended December 2025 of  Rs. 106.69  millions  grew by 140.35% from Rs. 44.39 millions.The company reported a good operating profit of 177.51 millions compared to 103.17 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 703.54 628.26 11.98 1984.23 2097.94 -5.42 2864.66 2851.55 0.46
Other Income 10.35 13.03 -20.57 34.56 37.06 -6.75 47.64 42.62 11.78
PBIDT 177.51 103.17 72.06 444.63 409.48 8.58 557.08 516.03 7.95
Interest 8.98 15.90 -43.52 30.75 41.18 -25.33 53.67 50.93 5.38
PBDT 168.53 87.27 93.11 413.88 368.30 12.38 503.41 465.10 8.24
Depreciation 22.11 22.36 -1.12 65.76 65.53 0.35 85.81 97.78 -12.24
PBT 146.42 64.91 125.57 348.12 302.77 14.98 417.60 367.32 13.69
TAX 39.73 20.52 93.62 90.96 80.70 12.71 99.18 95.73 3.60
Deferred Tax 15.50 3.90 297.44 23.54 4.71 399.79 -13.52 -0.62 2080.65
PAT 106.69 44.39 140.35 257.16 222.07 15.80 318.42 271.59 17.24
Equity 85.07 85.07 0.00 85.07 85.07 0.00 85.07 85.07 0.00
PBIDTM(%) 25.23 16.42 53.65 22.41 19.52 14.81 19.45 18.10 7.46

Hester Biosciences Share Price

1492.80 20.80 (1.41%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×